triiodothyronine has been researched along with Cardiac Failure in 113 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to conduct a systematic review and meta-analysis evaluating the role of thyroid hormone therapy in patients with heart failure and low-triiodothyronine syndrome." | 9.22 | The Effectiveness of Thyroid Hormone Replacement Therapy on Heart Failure and Low-Triiodothyronine Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Bao, Y; Chen, X; Shi, C; Tian, L, 2022) |
| "To assess whether levothyroxine treatment improves functional capacity in patients with chronic heart failure (New York Heart Association class i-iii) and subclinical hypothyroidism." | 9.17 | [Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism]. ( Angel, A; Cordero, DJ; Cortez Quiroga, GA; Curotto Grasiosi, J; Dak, M; Degregorio, A; Delgado, J; Esper, RJ; Filipini, EC; Izurieta, C; Machado, RA; Martínez Quesada, Mdel M; Peressotti, B; Rus Mansilla, C, 2013) |
| " These preliminary results indicate that LT3S reversibility by dobutamine is associated with short-term hemodynamic and neurohormonal improvement in patients with persistent severe heart failure." | 9.16 | Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome. ( Bonadei, I; Bugatti, S; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Rovetta, R; Vizzardi, E, 2012) |
| " We examined the relationship between low triiodothyronine (T3) levels and heart failure status, including B-type natriuretic peptide (BNP) levels, in 625 patients with cardiovascular disorders who underwent cardiac catheterization." | 8.02 | Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure. ( Kashiwagi, Y; Kimura, H; Minai, K; Nagoshi, T; Oi, Y; Takahashi, H; Tanaka, Y; Yoshimura, M, 2021) |
| " This study sought to investigate the prevalence and prognostic role of hypothyroidism, overt and subclinical, and of low free-triiodothyronine (fT3) levels in patients hospitalized with AHF." | 8.02 | Prognostic role of hypothyroidism and low free-triiodothyronine levels in patients hospitalized with acute heart failure. ( Bruno, C; Burzo, ML; Covino, M; De Matteis, G; Della Polla, DA; Franceschi, F; Gambassi, G; Mancini, A; Petti, A, 2021) |
| "Low triiodothyronine (T3) syndrome has recently been evaluated as a prognostic marker of acute heart failure (AHF)." | 7.96 | Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure. ( Asai, K; Asano, K; Goda, H; Hata, N; Kiuchi, K; Kobayashi, N; Matsushita, M; Okajima, F; Okazaki, H; Shibata, Y; Shigihara, S; Shimizu, W; Shirakabe, A; Tani, K, 2020) |
| " Oxidative stress present in heart failure (HF) and myocardial infarction (MI) might cause Se deficiency and decreased thyroxine to triiodothyronine conversion." | 7.91 | Selenium deficiency and the dynamics of changes of thyroid profile in patients with acute myocardial infarction and chronic heart failure. ( Czubek, U; Frączek-Jucha, M; Gackowski, A; Kabat, M; Nessler, J; Szlósarczyk, B, 2019) |
| "The aim of study was to evaluate the relationship of β-adrenergic receptors gene polymorphisms with low triiodothyronine syndrome in patients with a heart failure." | 7.91 | The association of polymorphisms of β-adrenergic receptors genes with the low triiodothyronine syndrome in patients with a heart failure. ( Bondar, TM; Galchinskaya, VY; Kopytsya, MP; Lozyk, TV; Pyvovar, SM; Rudyk, IS, 2019) |
| "To explore the prognostic role of free triiodothyronine (FT3) on all-cause mortality and heart failure (HF) hospitalization in patients receiving cardiac resynchronization therapy (CRT)." | 7.81 | [Association of serum free triiodothyronine with long-term outcome in heart failure patients receiving cardiac resynchronization therapy]. ( Chen, K; Ding, L; Hua, W; Liu, Z; Mi, J; Yang, S; Zhang, S, 2015) |
| "We assessed the prognostic implications of low triiodothyronine (T3) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in critically ill patients with acute heart failure." | 7.80 | Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. ( Chuang, CP; Jong, YS; Lo, HM; Wu, CY, 2014) |
| "The objective of this paper was to investigate the diagnostic and prognostic value of plasma B type natriuretic peptide (BNP) and serum triiodothyronine (T3) in chronic congestive heart failure (CHF)." | 7.78 | The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure. ( Da, CH; Du, JB; Guo, G; Guo, Y; Ju, TF; Xu, YP; Zhao, Y, 2012) |
| "Low plasma triiodothyronine (T(3)) levels are considered a prognostic predictor of death in heart failure (HF) patients." | 7.77 | Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage. ( Acosta, A; Anker, S; Boero, L; Brenta, G; Brites, F; Gómez Rosso, L; Sutton, M; Thierer, J; Vainstein, N, 2011) |
| "Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values." | 7.76 | Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. ( Acar, E; Ertas, G; Kilic, T; Kozdag, G; Sahin, T; Ural, D, 2010) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "We sought to explore the use of triiodothyronine (T(3)) concentrations as an adjunct to clinical and functional parameters when estimating prognosis in patients with chronic heart failure." | 7.73 | Triiodothyronine levels for risk stratification of patients with chronic heart failure. ( Iervasi, G; L'Abbate, A; Landi, P; Pingitore, A; Ripoli, A; Taddei, MC, 2005) |
| "In order to explore the relationship between congestive heart failure (CHF) and serum thyroxine, we assayed serum thyroxine level in 52 patients with CHF and 28 normal persons by means of radioimmunoassay (RIA)." | 7.70 | [Changes and clinical significance of serum thyroxine level in patients with congestive heart failure]. ( Fang, Y; Fu, Q; Yan, H, 1999) |
| "Triiodothyronine was well tolerated without episodes of ischemia or clinical arrhythmia." | 6.69 | Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. ( Child, JS; Chopra, IJ; Fonarow, GC; Goldhaber, JI; Hage, A; Hamilton, MA; Moriguchi, JD; Steimle, A; Stevenson, LW, 1998) |
| "Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4." | 6.41 | Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. ( Ascheim, DD; Hryniewicz, K, 2002) |
| "Low T3 syndrome is frequently found in patients with HFrEF and is associated with a poor outcome." | 5.51 | Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study. ( Fraczek-Jucha, M; Gackowski, A; Kabat, M; Nessler, J; Plens, K; Rychlak, R; Zbierska-Rubinkiewicz, K, 2019) |
| "Free triiodothyronine (FT3) levels were lower in the T2DM group compared with the nondiabetes group (P = 0." | 5.42 | Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes. ( Chen, P; Lei, X; Li, S; Liu, Z; Luo, Y; Wu, D; Xu, D, 2015) |
| "The purpose of this study was to conduct a systematic review and meta-analysis evaluating the role of thyroid hormone therapy in patients with heart failure and low-triiodothyronine syndrome." | 5.22 | The Effectiveness of Thyroid Hormone Replacement Therapy on Heart Failure and Low-Triiodothyronine Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Bao, Y; Chen, X; Shi, C; Tian, L, 2022) |
| "To assess whether levothyroxine treatment improves functional capacity in patients with chronic heart failure (New York Heart Association class i-iii) and subclinical hypothyroidism." | 5.17 | [Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism]. ( Angel, A; Cordero, DJ; Cortez Quiroga, GA; Curotto Grasiosi, J; Dak, M; Degregorio, A; Delgado, J; Esper, RJ; Filipini, EC; Izurieta, C; Machado, RA; Martínez Quesada, Mdel M; Peressotti, B; Rus Mansilla, C, 2013) |
| " These preliminary results indicate that LT3S reversibility by dobutamine is associated with short-term hemodynamic and neurohormonal improvement in patients with persistent severe heart failure." | 5.16 | Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome. ( Bonadei, I; Bugatti, S; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Rovetta, R; Vizzardi, E, 2012) |
| "Since the aim of the present review was to briefly overview both the indication and contraindication of triiodothyronine replacement in CHF and LT3S, the authors searched PubMed using the medical subject headings (MeSH) related to the following terms: "congestive heart failure" and "low T3 syndrome" or "euthyroid sick syndrome" or "non-thyroidal sick syndrome"." | 5.05 | Congestive Heart Failure and Thyroid Dysfunction: The Role of the Low T3 Syndrome and Therapeutic Aspects. ( De Tullio, A; Iacoviello, M; Lisco, G; Triggiani, V, 2020) |
| " Patients with overt or subclinical hypothyroidism should be treated with levothyroxine to improve their cardiovascular function and the potential risk of heart failure." | 5.01 | The Management of Thyroid Abnormalities in Chronic Heart Failure. ( Biondi, B, 2019) |
| "Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
| " In heart failure (HF) the main alteration of thyroid function is referred to as "low-triiodothyronine (T3) syndrome" (LT3S) characterized by decreased total serum T3 and free T3 (fT3) with normal levels of thyroxine (T4) and thyrotropin (TSH)." | 4.86 | The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence. ( Galli, E; Iervasi, G; Pingitore, A, 2010) |
| "It is still not clear how the free triiodothyronine (FT3) to free thyroxine (FT4) ratio affects the prognosis of acute myocardial infarction (AMI), especially the risk of heart failure (HF) subsequent to AMI." | 4.31 | Higher Peripheral Thyroid Sensitivity Is Linked to a Lower Risk of Heart Failure After Acute Myocardial Infarction. ( Fang, S; Lang, X; Li, L; Li, Y; Li, Z; Wu, N; Xing, L; Zhang, Y; Zhao, B, 2023) |
| " We examined the relationship between low triiodothyronine (T3) levels and heart failure status, including B-type natriuretic peptide (BNP) levels, in 625 patients with cardiovascular disorders who underwent cardiac catheterization." | 4.02 | Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure. ( Kashiwagi, Y; Kimura, H; Minai, K; Nagoshi, T; Oi, Y; Takahashi, H; Tanaka, Y; Yoshimura, M, 2021) |
| " This study sought to investigate the prevalence and prognostic role of hypothyroidism, overt and subclinical, and of low free-triiodothyronine (fT3) levels in patients hospitalized with AHF." | 4.02 | Prognostic role of hypothyroidism and low free-triiodothyronine levels in patients hospitalized with acute heart failure. ( Bruno, C; Burzo, ML; Covino, M; De Matteis, G; Della Polla, DA; Franceschi, F; Gambassi, G; Mancini, A; Petti, A, 2021) |
| "Severe cardiovascular diseases, such as myocardial infarction or heart failure, can alter thyroid hormone (TH) secretion and peripheral conversion, leading to low triiodothyronine (T3) syndrome." | 4.02 | Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1/PI3K/AKT signaling pathway. ( Liao, X; Liu, L; Ruan, H; Yang, B; Zeng, B; Zhang, C, 2021) |
| "Low triiodothyronine (T3) syndrome has recently been evaluated as a prognostic marker of acute heart failure (AHF)." | 3.96 | Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure. ( Asai, K; Asano, K; Goda, H; Hata, N; Kiuchi, K; Kobayashi, N; Matsushita, M; Okajima, F; Okazaki, H; Shibata, Y; Shigihara, S; Shimizu, W; Shirakabe, A; Tani, K, 2020) |
| " Oxidative stress present in heart failure (HF) and myocardial infarction (MI) might cause Se deficiency and decreased thyroxine to triiodothyronine conversion." | 3.91 | Selenium deficiency and the dynamics of changes of thyroid profile in patients with acute myocardial infarction and chronic heart failure. ( Czubek, U; Frączek-Jucha, M; Gackowski, A; Kabat, M; Nessler, J; Szlósarczyk, B, 2019) |
| "The aim of study was to evaluate the relationship of β-adrenergic receptors gene polymorphisms with low triiodothyronine syndrome in patients with a heart failure." | 3.91 | The association of polymorphisms of β-adrenergic receptors genes with the low triiodothyronine syndrome in patients with a heart failure. ( Bondar, TM; Galchinskaya, VY; Kopytsya, MP; Lozyk, TV; Pyvovar, SM; Rudyk, IS, 2019) |
| "To explore the prognostic role of free triiodothyronine (FT3) on all-cause mortality and heart failure (HF) hospitalization in patients receiving cardiac resynchronization therapy (CRT)." | 3.81 | [Association of serum free triiodothyronine with long-term outcome in heart failure patients receiving cardiac resynchronization therapy]. ( Chen, K; Ding, L; Hua, W; Liu, Z; Mi, J; Yang, S; Zhang, S, 2015) |
| "We assessed the prognostic implications of low triiodothyronine (T3) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in critically ill patients with acute heart failure." | 3.80 | Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. ( Chuang, CP; Jong, YS; Lo, HM; Wu, CY, 2014) |
| " Heart failure represents an intriguing clinical situation in which triiodothyronine treatment might be beneficial." | 3.80 | Cardiovascular disease and thyroid function. ( Faber, J; Selmer, C, 2014) |
| "9 mlU/l), subclinical hypothyroidism is defined as a raised TSH with normal serum free thyroxine (FT4) concentrations (9-19 pmol/l)." | 3.79 | Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study. ( Chackathayil, J; Davis, RC; Gill, PS; Hughes, E; Lip, GY; Patel, JV; Webster, C, 2013) |
| "The objective of this paper was to investigate the diagnostic and prognostic value of plasma B type natriuretic peptide (BNP) and serum triiodothyronine (T3) in chronic congestive heart failure (CHF)." | 3.78 | The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure. ( Da, CH; Du, JB; Guo, G; Guo, Y; Ju, TF; Xu, YP; Zhao, Y, 2012) |
| "Low plasma triiodothyronine (T(3)) levels are considered a prognostic predictor of death in heart failure (HF) patients." | 3.77 | Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage. ( Acosta, A; Anker, S; Boero, L; Brenta, G; Brites, F; Gómez Rosso, L; Sutton, M; Thierer, J; Vainstein, N, 2011) |
| "Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values." | 3.76 | Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. ( Acar, E; Ertas, G; Kilic, T; Kozdag, G; Sahin, T; Ural, D, 2010) |
| "Patients with congestive heart failure (CHF) often have low serum triiodothyronine (T(3)) concentrations." | 3.75 | Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. ( Danzi, S; Henderson, KK; Klein, I; Leya, G; Paul, JT; Samarel, AM, 2009) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "We sought to explore the use of triiodothyronine (T(3)) concentrations as an adjunct to clinical and functional parameters when estimating prognosis in patients with chronic heart failure." | 3.73 | Triiodothyronine levels for risk stratification of patients with chronic heart failure. ( Iervasi, G; L'Abbate, A; Landi, P; Pingitore, A; Ripoli, A; Taddei, MC, 2005) |
| "To study the relationship between the TCM Syndrome Differentiation-types of congestive heart failure (CHF) and thyroid hormones, including triiodothyronine (T3), thyroxine (T4) and thyroid stimulating hormone (TSH), and atrial natriuretic peptide (ANP), as well as cardiac function parameters, including left ventricular ejection fraction (LVEF), mean velocity of circumferentid fiber shortening (mVcf) and A peak/E peak (A/E)." | 3.72 | [Study on relationship among thyroid hormone relativity and Syndrome Differentiation-types of TCM in patients with congestive heart failure]. ( Chen, J; Cheng, X; Gao, XL; Huang, S; Huang, T; Pei, Y; Sheng, L; Shi, D; Wang, L; Yan, X; Yang, A; Zhang, BZ; Zhou, J, 2004) |
| "In order to explore the relationship between congestive heart failure (CHF) and serum thyroxine, we assayed serum thyroxine level in 52 patients with CHF and 28 normal persons by means of radioimmunoassay (RIA)." | 3.70 | [Changes and clinical significance of serum thyroxine level in patients with congestive heart failure]. ( Fang, Y; Fu, Q; Yan, H, 1999) |
| "The effects of spontaneous and experimentally induced congestive heart failure on serum thyroxine (T4), 3,5,3'-triiodothyronine (T3), 3,3'5'-triiodothyronine (reverse T3), free T4, free T3 concentrations, and the serum T4 and T3 concentrations in response to administration of thyrotropin were studied." | 3.69 | Thyroid function in dogs with spontaneous and induced congestive heart failure. ( Panciera, DL; Refsal, KR, 1994) |
| "To determine the prevalence and significance of abnormal thyroid hormone metabolism in congestive heart failure, free thyroxine (T4) index, free triiodothyronine (T3) index, reverse T3 and thyrotropin levels were obtained in 84 hospitalized patients with chronic advanced heart failure." | 3.68 | Altered thyroid hormone metabolism in advanced heart failure. ( Hamilton, MA; Luu, M; Stevenson, LW; Walden, JA, 1990) |
| "Serum total thyroxine, triiodothyronine and thyrotropin response to thyrotropin-releasing hormone were measured in 75 consecutive patients presenting to a cardiology clinic with atrial fibrillation with no obvious cardiovascular cause." | 3.66 | Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. ( Forfar, JC; Miller, HC; Toft, AD, 1979) |
| "Triiodothyronine was well tolerated without episodes of ischemia or clinical arrhythmia." | 2.69 | Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. ( Child, JS; Chopra, IJ; Fonarow, GC; Goldhaber, JI; Hage, A; Hamilton, MA; Moriguchi, JD; Steimle, A; Stevenson, LW, 1998) |
| "Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4." | 2.41 | Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. ( Ascheim, DD; Hryniewicz, K, 2002) |
| "Low T3 syndrome is frequently found in patients with HFrEF and is associated with a poor outcome." | 1.51 | Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study. ( Fraczek-Jucha, M; Gackowski, A; Kabat, M; Nessler, J; Plens, K; Rychlak, R; Zbierska-Rubinkiewicz, K, 2019) |
| "Free triiodothyronine (FT3) levels were lower in the T2DM group compared with the nondiabetes group (P = 0." | 1.42 | Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes. ( Chen, P; Lei, X; Li, S; Liu, Z; Luo, Y; Wu, D; Xu, D, 2015) |
| "To analyze occurrence of thyroid dysfunction due to regular long-term intake of amiodaron (for one year), to search for predictors of amiodaron-induced hypothyroidism and thyrotoxicosis." | 1.33 | [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron]. ( Bakalov, SA; Golitsyn, SP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
| "Sick euthyroid syndrome is defined as the decrease of serum free triiodothyronine with normal free L-thyroxin and thyrotropin." | 1.31 | Heart failure accompanied by sick euthyroid syndrome and exercise training. ( Boudonas, G; Efthimiadis, A; Keskilidis, C; Lefkos, N; Psirropoulos, D; Tsapas, G; Vogas, V, 2002) |
| "Resolution of dilated cardiomyopathy with normalization of systolic function was achieved in five patients, and improvement from severe to mild left ventricular dysfunction was observed in two patients." | 1.29 | Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism. ( Challapalli, S; Patterson, C; Umpierrez, GE, 1995) |
| "Patients with ventricular tachycardia demonstrated significantly lower serum values of FT3 and FT3/FT4, and significantly higher values of rT3." | 1.29 | [Serum thyroid hormone levels correlate with cardiac function and ventricular tachyarrhythmia in patients with chronic heart failure]. ( Inoue, T; Maeda, T; Niwa, H; Saikawa, T; Shimoyama, N, 1993) |
| "Patients with advanced congestive heart failure are often severely ill and may experience substantial abnormalities in thyroid hormone metabolism." | 1.29 | Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. ( Hamilton, MA, 1993) |
| " A transient decrease in total T4, elevation in the T3 resin uptake and consequent increase in the free T4 index (FT4I) were seen 2-5 h after ingestion of frusemide at a chronic morning dosage of 80, 120 or 250 mg." | 1.27 | Effect of oral frusemide on diagnostic indices of thyroid function. ( Hamblin, PS; Lim, CF; Long, F; Newnham, HH; Stockigt, JR; Topliss, DJ, 1987) |
| "In patients with effort syndrome and hyperthyroidism, MTTs were often, but not always shortened below the control values; consequently, in case of associated heart disease, MTT-prolongation may be masked in such instances where hyperthyroidism causes MTT shortening." | 1.25 | [Minimal cardiac transit time in thyroid disorders and in the effort syndrome]. ( Becker, V; Feinendegen, LE; Schicha, H; Siebers, G; Vyska, K, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (12.39) | 18.7374 |
| 1990's | 16 (14.16) | 18.2507 |
| 2000's | 30 (26.55) | 29.6817 |
| 2010's | 39 (34.51) | 24.3611 |
| 2020's | 14 (12.39) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, H | 1 |
| Kashiwagi, Y | 1 |
| Nagoshi, T | 1 |
| Tanaka, Y | 1 |
| Oi, Y | 1 |
| Kimura, H | 1 |
| Minai, K | 1 |
| Yoshimura, M | 1 |
| Danzi, S | 4 |
| Klein, I | 6 |
| Shi, C | 1 |
| Bao, Y | 1 |
| Chen, X | 1 |
| Tian, L | 1 |
| Lang, X | 1 |
| Zhao, B | 1 |
| Fang, S | 1 |
| Li, L | 1 |
| Li, Z | 1 |
| Wu, N | 1 |
| Zhang, Y | 4 |
| Xing, L | 1 |
| Li, Y | 1 |
| Neves, JS | 2 |
| Leite, AR | 2 |
| Conceição, G | 1 |
| Gonçalves, A | 1 |
| Borges-Canha, M | 2 |
| Vale, C | 2 |
| Von-Hafe, M | 1 |
| Martins, D | 1 |
| Miranda-Silva, D | 1 |
| Leite, S | 1 |
| Rocha-Oliveira, E | 1 |
| Sousa-Mendes, C | 1 |
| Chaves, J | 1 |
| Lourenço, IM | 1 |
| Grijota-Martínez, C | 1 |
| Bárez-López, S | 1 |
| Miranda, IM | 1 |
| Almeida-Coelho, J | 1 |
| Vasques-Nóvoa, F | 2 |
| Carvalho, D | 1 |
| Lourenço, A | 1 |
| Falcão-Pires, I | 1 |
| Leite-Moreira, A | 2 |
| Angélico-Gonçalves, A | 1 |
| Saraiva, FA | 1 |
| Pinho, IB | 1 |
| Oliveira, AC | 1 |
| von Hafe, M | 1 |
| Lourenço, AP | 1 |
| Macedo, F | 1 |
| Araújo, JP | 1 |
| von Hafe, P | 1 |
| Almeida, J | 1 |
| Ferreira, JP | 1 |
| Turić, I | 1 |
| Velat, I | 1 |
| Bušić, Ž | 1 |
| Čulić, V | 1 |
| Lisco, G | 1 |
| De Tullio, A | 1 |
| Iacoviello, M | 2 |
| Triggiani, V | 2 |
| Asai, K | 1 |
| Shirakabe, A | 1 |
| Kiuchi, K | 1 |
| Kobayashi, N | 1 |
| Okazaki, H | 1 |
| Matsushita, M | 1 |
| Shibata, Y | 1 |
| Goda, H | 1 |
| Shigihara, S | 1 |
| Asano, K | 1 |
| Tani, K | 1 |
| Okajima, F | 1 |
| Hata, N | 1 |
| Shimizu, W | 1 |
| An, S | 1 |
| Gilani, N | 1 |
| Huang, Y | 1 |
| Muncan, A | 1 |
| Tang, YD | 1 |
| Gerdes, AM | 4 |
| Ojamaa, K | 3 |
| Pyvovar, SM | 2 |
| Rudyk, IS | 2 |
| Kopytsya, MP | 2 |
| Lozyk, TV | 2 |
| Galchinskaya, VY | 1 |
| Bondar, TM | 1 |
| Stefanelli, S | 1 |
| Michou, E | 1 |
| Strebel, I | 1 |
| Lopez-Ayala, P | 1 |
| Mueller, C | 1 |
| Galchinskaya, VI | 1 |
| Chenchik, TO | 1 |
| Zeng, B | 1 |
| Liao, X | 1 |
| Liu, L | 1 |
| Zhang, C | 1 |
| Ruan, H | 1 |
| Yang, B | 1 |
| De Matteis, G | 1 |
| Covino, M | 1 |
| Burzo, ML | 1 |
| Della Polla, DA | 1 |
| Petti, A | 1 |
| Bruno, C | 1 |
| Franceschi, F | 1 |
| Mancini, A | 1 |
| Gambassi, G | 1 |
| Cetin, EH | 1 |
| Cetin, MS | 1 |
| Könte, HC | 1 |
| Ocak, K | 1 |
| Yaman, NM | 1 |
| Hepsen, S | 1 |
| Ozeke, O | 1 |
| Temizhan, A | 1 |
| Topaloglu, S | 1 |
| Aras, D | 1 |
| Chen, YY | 1 |
| Shu, XR | 1 |
| Su, ZZ | 1 |
| Lin, RJ | 1 |
| Zhang, HF | 1 |
| Yuan, WL | 1 |
| Wang, JF | 1 |
| Xie, SL | 1 |
| Kannan, L | 1 |
| Shaw, PA | 1 |
| Morley, MP | 1 |
| Brandimarto, J | 1 |
| Fang, JC | 1 |
| Sweitzer, NK | 1 |
| Cappola, TP | 1 |
| Cappola, AR | 1 |
| Fraczek-Jucha, M | 2 |
| Zbierska-Rubinkiewicz, K | 1 |
| Kabat, M | 2 |
| Plens, K | 1 |
| Rychlak, R | 1 |
| Nessler, J | 2 |
| Gackowski, A | 2 |
| Szlósarczyk, B | 1 |
| Czubek, U | 1 |
| Biondi, B | 2 |
| Pyvovar, S | 1 |
| Rudyk, Y | 1 |
| Lozyk, T | 1 |
| Galchinskaya, V | 1 |
| Chenchik, T | 1 |
| Vasiliadis, I | 1 |
| Kolovou, G | 1 |
| Kolovou, V | 1 |
| Giannakopoulou, V | 1 |
| Boutsikou, M | 1 |
| Katsiki, N | 1 |
| Papadopoulou, E | 1 |
| Mavrogeni, S | 1 |
| Sorontila, K | 1 |
| Pantos, C | 1 |
| Cokkinos, DV | 1 |
| Curotto Grasiosi, J | 1 |
| Peressotti, B | 1 |
| Machado, RA | 1 |
| Filipini, EC | 1 |
| Angel, A | 1 |
| Delgado, J | 1 |
| Cortez Quiroga, GA | 1 |
| Rus Mansilla, C | 1 |
| Martínez Quesada, Mdel M | 1 |
| Degregorio, A | 1 |
| Cordero, DJ | 1 |
| Dak, M | 1 |
| Izurieta, C | 1 |
| Esper, RJ | 1 |
| Gill, PS | 1 |
| Patel, JV | 1 |
| Chackathayil, J | 1 |
| Webster, C | 1 |
| Davis, RC | 1 |
| Hughes, E | 1 |
| Lip, GY | 1 |
| Chuang, CP | 1 |
| Jong, YS | 1 |
| Wu, CY | 1 |
| Lo, HM | 1 |
| Faber, J | 1 |
| Selmer, C | 1 |
| Okayama, D | 1 |
| Minami, Y | 1 |
| Kataoka, S | 1 |
| Shiga, T | 1 |
| Hagiwara, N | 1 |
| Kishi, T | 1 |
| Chen, P | 1 |
| Li, S | 1 |
| Lei, X | 1 |
| Liu, Z | 2 |
| Wu, D | 1 |
| Luo, Y | 1 |
| Xu, D | 1 |
| Weltman, NY | 2 |
| Pol, CJ | 1 |
| Wang, Y | 1 |
| Koder, A | 1 |
| Raza, S | 1 |
| Zucchi, R | 1 |
| Saba, A | 1 |
| Colligiani, D | 1 |
| Mi, J | 1 |
| Yang, S | 1 |
| Hua, W | 1 |
| Chen, K | 1 |
| Ding, L | 1 |
| Zhang, S | 1 |
| Jakowczuk, M | 1 |
| Zalas, D | 1 |
| Owecki, M | 1 |
| Rouf, R | 1 |
| Greytak, S | 1 |
| Wooten, EC | 1 |
| Wu, J | 1 |
| Boltax, J | 1 |
| Picard, M | 1 |
| Svensson, EC | 1 |
| Dillmann, WH | 1 |
| Patten, RD | 1 |
| Huggins, GS | 1 |
| Guida, P | 1 |
| Guastamacchia, E | 1 |
| Forleo, C | 1 |
| Catanzaro, R | 1 |
| Cicala, M | 1 |
| Basile, M | 1 |
| Sorrentino, S | 1 |
| Favale, S | 1 |
| Galli, E | 2 |
| Pingitore, A | 6 |
| Iervasi, G | 8 |
| Pimentel, CR | 1 |
| Miano, FA | 1 |
| Perone, D | 2 |
| Conde, SJ | 1 |
| Luvizotto, Rde A | 1 |
| Padovani, CR | 1 |
| Cicogna, AC | 2 |
| Filho, FR | 1 |
| Nogueira, CR | 2 |
| Dark, JH | 1 |
| Ertugrul, DT | 1 |
| Yavuz, B | 1 |
| Ata, N | 1 |
| Yalcin, AA | 1 |
| Kucukazman, M | 1 |
| Algul, B | 1 |
| Dal, K | 1 |
| Akin, KO | 1 |
| Deveci, OS | 1 |
| Canbolat, N | 1 |
| Ure, OS | 1 |
| Tutal, E | 1 |
| Saccà, L | 1 |
| Henderson, KK | 1 |
| Paul, JT | 1 |
| Leya, G | 1 |
| Samarel, AM | 1 |
| Lubrano, V | 1 |
| Carpi, A | 1 |
| Ladenson, PW | 1 |
| McCarren, M | 1 |
| Morkin, E | 3 |
| Edson, RG | 1 |
| Shih, MC | 1 |
| Warren, SR | 1 |
| Barnhill, JG | 1 |
| Churby, L | 1 |
| Thai, H | 1 |
| O'Brien, T | 1 |
| Anand, I | 1 |
| Warner, A | 1 |
| Hattler, B | 1 |
| Dunlap, M | 1 |
| Erikson, J | 1 |
| Goldman, S | 3 |
| Fontana, M | 1 |
| Passino, C | 1 |
| Poletti, R | 1 |
| Zyw, L | 1 |
| Prontera, C | 1 |
| Scarlattini, M | 2 |
| Clerico, A | 1 |
| Emdin, M | 1 |
| Kozdag, G | 3 |
| Ertas, G | 2 |
| Kilic, T | 1 |
| Acar, E | 1 |
| Sahin, T | 1 |
| Ural, D | 3 |
| G Pearse, S | 1 |
| D Dahdal, M | 1 |
| Grocott-Mason, R | 1 |
| W Dubrey, S | 1 |
| Brenta, G | 1 |
| Thierer, J | 1 |
| Sutton, M | 1 |
| Acosta, A | 1 |
| Vainstein, N | 1 |
| Brites, F | 1 |
| Boero, L | 1 |
| Gómez Rosso, L | 1 |
| Anker, S | 1 |
| Celikyurt, U | 1 |
| Agacdiken, A | 1 |
| Geyik, B | 1 |
| Vural, A | 1 |
| Savinova, OV | 1 |
| Liu, Y | 1 |
| Aasen, GA | 1 |
| Mao, K | 1 |
| Nedich, BL | 1 |
| Liang, Q | 1 |
| Aygün, F | 1 |
| Emre, E | 1 |
| Kirbaş, A | 1 |
| Soran, O | 1 |
| Kobusiak-Prokopowicz, M | 1 |
| Sciborski, K | 1 |
| Mysiak, A | 1 |
| Selvaraj, S | 1 |
| Akhter, N | 1 |
| Bonow, RO | 1 |
| Shah, SJ | 1 |
| Mishra, P | 1 |
| Samanta, L | 1 |
| D'Aloia, A | 1 |
| Vizzardi, E | 1 |
| Bugatti, S | 1 |
| Rovetta, R | 1 |
| Bonadei, I | 1 |
| Del Magro, F | 1 |
| Curnis, A | 1 |
| Dei Cas, L | 1 |
| Asvold, BO | 1 |
| Bjøro, T | 1 |
| Platou, C | 1 |
| Vatten, LJ | 1 |
| Du, JB | 1 |
| Da, CH | 1 |
| Zhao, Y | 1 |
| Guo, Y | 1 |
| Guo, G | 1 |
| Ju, TF | 1 |
| Xu, YP | 1 |
| Mezősi, E | 1 |
| Bajnok, L | 1 |
| Tóth, K | 1 |
| Ascheim, DD | 2 |
| Hryniewicz, K | 1 |
| Fang, Y | 1 |
| Fu, Q | 1 |
| Yan, H | 1 |
| SPANAR, E | 1 |
| BALAZ, V | 1 |
| BANSI, HW | 1 |
| OLSEN, JM | 1 |
| CAVALIERI, RR | 1 |
| SEARLE, GL | 1 |
| Minakawa, M | 1 |
| Takeuchi, K | 1 |
| Ito, K | 1 |
| Tsushima, T | 1 |
| Fukui, K | 1 |
| Takaya, S | 1 |
| Fukuda, I | 1 |
| Telkova, IL | 2 |
| Karpov, RS | 1 |
| Tepliakov, AT | 1 |
| Zhou, J | 1 |
| Gao, XL | 1 |
| Zhang, BZ | 1 |
| Huang, S | 1 |
| Wang, L | 1 |
| Sheng, L | 1 |
| Shi, D | 1 |
| Yan, X | 1 |
| Yang, A | 1 |
| Huang, T | 1 |
| Pei, Y | 1 |
| Chen, J | 1 |
| Cheng, X | 1 |
| Landi, P | 1 |
| Taddei, MC | 1 |
| Ripoli, A | 1 |
| L'Abbate, A | 2 |
| Opalińska-Ciszek, E | 1 |
| Niemczyk, S | 1 |
| Matuszkiewicz-Rowińska, J | 1 |
| Serdiuk, SE | 1 |
| Bakalov, SA | 1 |
| Golitsyn, SP | 1 |
| Molashenko, NV | 1 |
| Platonova, NM | 1 |
| Sviridenko, NIu | 1 |
| Bauab, RC | 1 |
| Castro, AV | 1 |
| Schmidt-Ott, UM | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Bogazzi, F | 1 |
| Ambrosini, CE | 1 |
| Martino, E | 1 |
| Miccoli, P | 1 |
| Andreoli, M | 1 |
| Pinelli, M | 1 |
| Bindi, M | 1 |
| Cassetti, G | 1 |
| Moroni, F | 1 |
| Pandolfo, C | 1 |
| Rosada, J | 1 |
| Castiglioni, M | 1 |
| Barison, A | 1 |
| Iervasi, A | 1 |
| Nucci, D | 1 |
| Mariotti, R | 1 |
| Portman, MA | 1 |
| Sterling, FH | 1 |
| Richter, JS | 1 |
| Giampetro, AM | 1 |
| Lada, W | 1 |
| Czech, W | 1 |
| Kaniewski, M | 1 |
| Putkiewicz, K | 1 |
| Kuch, J | 1 |
| Piwowarczyk, K | 1 |
| Luczak, D | 1 |
| Biro, E | 1 |
| Umpierrez, GE | 1 |
| Challapalli, S | 1 |
| Patterson, C | 1 |
| Jones, RE | 1 |
| Panciera, DL | 1 |
| Refsal, KR | 1 |
| Shimoyama, N | 1 |
| Maeda, T | 1 |
| Inoue, T | 1 |
| Niwa, H | 1 |
| Saikawa, T | 1 |
| Hamilton, MA | 4 |
| Pennock, GD | 2 |
| Raya, TE | 2 |
| Bahl, JJ | 2 |
| Stevenson, LW | 3 |
| Kimura, T | 1 |
| Kanda, T | 1 |
| Kuwabara, A | 1 |
| Shinohara, H | 1 |
| Kobayashi, I | 1 |
| Fonarow, GC | 1 |
| Steimle, A | 1 |
| Goldhaber, JI | 1 |
| Child, JS | 1 |
| Chopra, IJ | 1 |
| Moriguchi, JD | 1 |
| Hage, A | 1 |
| Fadel, BM | 1 |
| Ellahham, S | 1 |
| Ringel, MD | 1 |
| Lindsay, J | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Sussman, MA | 1 |
| Ikeda, H | 1 |
| Dai, X | 1 |
| Zhou, Y | 1 |
| Yu, X | 1 |
| Dahlen, R | 1 |
| Psirropoulos, D | 1 |
| Lefkos, N | 1 |
| Boudonas, G | 1 |
| Efthimiadis, A | 1 |
| Vogas, V | 1 |
| Keskilidis, C | 1 |
| Tsapas, G | 1 |
| Birkhäuser, M | 1 |
| Burer, T | 1 |
| Busset, R | 1 |
| Burger, A | 1 |
| Forfar, JC | 1 |
| Miller, HC | 1 |
| Toft, AD | 1 |
| Siebers, G | 1 |
| Schicha, H | 1 |
| Becker, V | 1 |
| Vyska, K | 1 |
| Feinendegen, LE | 1 |
| Suzuki, Y | 1 |
| Nanno, M | 1 |
| Gemma, R | 1 |
| Yoshimi, T | 1 |
| Salter, DR | 1 |
| Dyke, CM | 1 |
| Wechsler, AS | 1 |
| Luu, M | 1 |
| Walden, JA | 1 |
| Stockigt, JR | 2 |
| Topliss, DJ | 2 |
| Koga, H | 1 |
| Kaku, T | 1 |
| Hashiba, K | 1 |
| Newnham, HH | 1 |
| Hamblin, PS | 1 |
| Long, F | 1 |
| Lim, CF | 1 |
| Földes, J | 1 |
| Lengyel, Z | 1 |
| Gesztesi, E | 1 |
| Takács, I | 1 |
| Nielsen, TP | 1 |
| Bodfish, RE | 1 |
| Kabok, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
23 reviews available for triiodothyronine and Cardiac Failure
| Article | Year |
|---|---|
Thyroid Abnormalities in Heart Failure.
Topics: Heart Failure; Humans; Hypothyroidism; Thyroid Diseases; Triiodothyronine | 2022 |
The Effectiveness of Thyroid Hormone Replacement Therapy on Heart Failure and Low-Triiodothyronine Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials.
Topics: Heart Failure; Hormone Replacement Therapy; Humans; Randomized Controlled Trials as Topic; Stroke Vo | 2022 |
Congestive Heart Failure and Thyroid Dysfunction: The Role of the Low T3 Syndrome and Therapeutic Aspects.
Topics: Animals; Heart Failure; Hormone Replacement Therapy; Humans; Thyroid Diseases; Triiodothyronine | 2020 |
The Management of Thyroid Abnormalities in Chronic Heart Failure.
Topics: Disease Management; Disease Progression; Heart Failure; Hormone Replacement Therapy; Humans; Thyroid | 2019 |
The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.
Topics: Heart Failure; Humans; Hypothyroidism; Prognosis; Thyroid Hormones; Triiodothyronine; Ventricular Fu | 2010 |
Heart failure as a multiple hormonal deficiency syndrome.
Topics: Animals; Disease Progression; Exercise Tolerance; Heart; Heart Failure; Hormones; Humans; Insulin Re | 2009 |
Thyroid replacement therapy and heart failure.
Topics: Animals; Cardiovascular Diseases; Diiodothyronines; Disease Models, Animal; Glomerular Filtration Ra | 2010 |
Oxidative stress and heart failure in altered thyroid States.
Topics: Animals; Atherosclerosis; Cardiomyopathies; Coronary Artery Disease; Heart Defects, Congenital; Hear | 2012 |
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
[The heart as an endocrine organ].
Topics: Adipocytes; Adipokines; Aldosterone; Biomarkers; Cardiomegaly; Coronary Artery Disease; Cytokines; H | 2012 |
Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state.
Topics: Adult; Aged; Cohort Studies; Female; Heart Failure; Humans; Hypothyroidism; Male; Middle Aged; Preva | 2002 |
[Role of thyroid hormones in regulation of heart function].
Topics: Arrhythmias, Cardiac; Heart; Heart Conduction System; Heart Failure; Heart Rate; Humans; Hyperthyroi | 2004 |
[Thyroid function and heart failure: from the new clinical evidences to the potential therapeutical implications].
Topics: Animals; Biomarkers; Heart Failure; Humans; Hypothyroidism; Predictive Value of Tests; Prognosis; Tr | 2005 |
Thyroid hormone and heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Failure; Humans; Thyroid Diseases; Thyroxine; Triiodothyro | 2006 |
[Pathophysiological and clinical correlations between endocrine and cardiovascular systems. An inter-systemic model of internal medicine].
Topics: Atrial Natriuretic Factor; Cardiovascular System; Diabetes Mellitus; Endocrine System; Endothelium, | 2006 |
Triiodothyronine (T3) effects on cardiovascular system in patients with heart failure.
Topics: Animals; Cardiovascular Physiological Phenomena; Heart Failure; Humans; Patents as Topic; Thyroid Ho | 2008 |
Thyroid hormone regulation of heart metabolism.
Topics: Animals; Energy Metabolism; Gene Expression Regulation; Heart Failure; Humans; Mitochondria, Heart; | 2008 |
Thyroid hormone abnormalities in heart failure: possibilities for therapy.
Topics: Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Safety; Thyroid Hormones; Thyroxine; Tr | 1996 |
Development of a thyroid hormone analogue for the treatment of congestive heart failure.
Topics: Animals; Cardiotonic Agents; Diiodothyronines; Disease Models, Animal; Drug Design; Drug Evaluation, | 1996 |
Hyperthyroid heart disease.
Topics: Atrial Fibrillation; Heart; Heart Diseases; Heart Failure; Humans; Hyperthyroidism; Myocardial Contr | 2000 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
[New clinical laboratory tests for endocrine and metabolism disorders].
Topics: Adrenomedullin; Atrial Natriuretic Factor; Autoantibodies; Biomarkers; Bone Diseases, Metabolic; Dia | 2001 |
Triiodothyronine (T3) and cardiovascular therapeutics: a review.
Topics: Cardiopulmonary Bypass; Chronic Disease; Heart Failure; Hemodynamics; Humans; Tissue Donors; Triiodo | 1992 |
7 trials available for triiodothyronine and Cardiac Failure
| Article | Year |
|---|---|
[Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism].
Topics: Aged; Cardiovascular Agents; Comorbidity; Exercise Test; Female; Follow-Up Studies; Heart Failure; H | 2013 |
Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.
Topics: Aged; Body Mass Index; Body Weight; Chronic Disease; Diiodothyronines; Dose-Response Relationship, D | 2010 |
Clinical effects of enhanced external counterpulsation treatment in patients with ischemic heart failure.
Topics: Aged; Blood Pressure; Cohort Studies; Counterpulsation; Electrocardiography; Female; Heart Failure; | 2012 |
Effect of intravenous dopamine infusion on pituitary and thyroid function and on nephroprotection.
Topics: Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Dopamine; Female; Heart Failure; Humans; Infus | 2012 |
Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Euthyroid Sick Syndromes; Heart Failure; Hemody | 2012 |
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study.
Topics: Aged; Cardiomyopathy, Dilated; Chronic Disease; Euthyroid Sick Syndromes; Female; Heart; Heart Failu | 2008 |
Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.
Topics: Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intravenous; Male; | 1998 |
83 other studies available for triiodothyronine and Cardiac Failure
| Article | Year |
|---|---|
Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure.
Topics: Aged; Biomarkers; Body Mass Index; Female; Glomerular Filtration Rate; Heart Disease Risk Factors; H | 2021 |
Higher Peripheral Thyroid Sensitivity Is Linked to a Lower Risk of Heart Failure After Acute Myocardial Infarction.
Topics: Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Thyr | 2023 |
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
Topics: Animals; Calcium; Disease Models, Animal; Heart Failure; Obesity; Rats; Stroke Volume; Triiodothyron | 2023 |
Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort.
Topics: Aged; Female; Heart Failure; Humans; Male; Stroke Volume; Thyroxine; Triiodothyronine; Ventricular F | 2023 |
Circulating thyroid hormones and clinical parameters of heart failure in men.
Topics: Aged; Biomarkers; Cross-Sectional Studies; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; | 2023 |
Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Cause of Death; Female; Follow-Up Studies; Heart | 2020 |
Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose triiodothyronine treatment.
Topics: Animals; Calcium; Cells, Cultured; Female; Heart Failure; Myocytes, Cardiac; Rats; Rats, Sprague-Daw | 2019 |
The association of polymorphisms of β-adrenergic receptors genes with the low triiodothyronine syndrome in patients with a heart failure.
Topics: Euthyroid Sick Syndromes; Genotype; Heart Failure; Humans; Polymorphism, Genetic; Receptors, Adrener | 2019 |
Reader's Comment on "Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure".
Topics: Aging; Euthyroid Sick Syndromes; Heart Failure; Humans; Malnutrition; Triiodothyronine | 2020 |
The effect of beta-blockers on a course of chronic heart failure in patients with a low triiodothyronine syndrome.
Topics: Adrenergic beta-Antagonists; Euthyroid Sick Syndromes; Follow-Up Studies; Heart Failure; Humans; Tri | 2020 |
Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1/PI3K/AKT signaling pathway.
Topics: Animals; Apoptosis; Atrial Remodeling; Cardiotonic Agents; Fibrosis; Heart Failure; Male; Mice; Mice | 2021 |
Prognostic role of hypothyroidism and low free-triiodothyronine levels in patients hospitalized with acute heart failure.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Area Under Curve; Chi-Square Distribution; Emergency | 2021 |
Lower levels of triiodothyronine are associated with poor hemodynamic profile and all-cause mortality in heart failure.
Topics: Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Survival R | 2021 |
A Low-Normal Free Triiodothyronine Level Is Associated with Adverse Prognosis in Euthyroid Patients with Heart Failure Receiving Cardiac Resynchronization Therapy.
Topics: Aged; Cardiac Resynchronization Therapy; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis | 2017 |
Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes.
Topics: Adult; Aged; Asymptomatic Diseases; Biomarkers; Comorbidity; Female; Heart Failure; Humans; Hypothyr | 2018 |
Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study.
Topics: Aged; Biomarkers; Euthyroid Sick Syndromes; Female; Heart Failure; Humans; Male; Middle Aged; Pilot | 2019 |
Selenium deficiency and the dynamics of changes of thyroid profile in patients with acute myocardial infarction and chronic heart failure.
Topics: Aged; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Poland; Selenium; Thy | 2019 |
[THE SYNDROME «LOW TRIIODOTHYRONINE» AND A COURSE A HEART FAILURE].
Topics: Heart Failure; Hospitalization; Humans; Myocardial Infarction; Thyroid Hormones; Triiodothyronine | 2019 |
Gene polymorphisms and thyroid function in patients with heart failure.
Topics: Aged; Cohort Studies; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; NF-kappa B p50 Sub | 2014 |
Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study.
Topics: Aged; Asian People; Black People; Cross-Sectional Studies; Female; Heart Failure; Humans; Hyperthyro | 2013 |
Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
Topics: Aged; Aged, 80 and over; Comorbidity; Coronary Artery Disease; Critical Illness; Diabetic Angiopathi | 2014 |
Cardiovascular disease and thyroid function.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiovascular Diseases; Female; Heart; Heart F | 2014 |
Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure.
Topics: Aged; Female; Heart Failure; Hospital Mortality; Hospitalization; Humans; Japan; Male; Multivariate | 2015 |
Free triiodothyronine, not thyroid stimulating hormone, should be focused on for risk stratification in acute decompensated heart failure.
Topics: Female; Heart Failure; Humans; Male; Triiodothyronine | 2015 |
Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes.
Topics: Aged; Chronic Disease; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart Failure; Humans; M | 2015 |
Long-term physiological T3 supplementation in hypertensive heart disease in rats.
Topics: Animals; Collagen; Female; Heart; Heart Failure; Heart Ventricles; Hypertension; Hypothyroidism; Myo | 2015 |
[Association of serum free triiodothyronine with long-term outcome in heart failure patients receiving cardiac resynchronization therapy].
Topics: Cardiac Resynchronization Therapy; Cohort Studies; Heart Failure; Heart Transplantation; Hospitaliza | 2015 |
Permanent atrial fibrillation in heart failure patients as another condition with increased reverse triiodothyronine concentration.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Cohort Studies; Female; Heart Fa | 2016 |
Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription.
Topics: Animals; Cardiomyopathies; Cell Line; DNA-Binding Proteins; Echocardiography; Heart Failure; Humans; | 2008 |
Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients.
Topics: Aged; Chronic Disease; Disease Progression; Echocardiography; Electrocardiography; Female; Follow-Up | 2008 |
Reverse T3 as a parameter of myocardial function impairment in heart failure.
Topics: Euthyroid Sick Syndromes; Female; Heart Failure; Heart Function Tests; Humans; Male; Triiodothyronin | 2010 |
More and better donors for cardiac transplantation.
Topics: Animals; Heart; Heart Failure; Heart Transplantation; Humans; Tissue and Organ Procurement; Tissue D | 2009 |
Decreasing brain natriuretic peptide levels after treatment for hyperthyroidism.
Topics: Adult; Diagnostic Errors; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Hy | 2009 |
Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Topics: Animals; Blood Pressure; Diastole; Disease Models, Animal; Gene Expression Regulation; Heart Failure | 2009 |
Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
Topics: Adult; Aged; C-Reactive Protein; Disease Progression; Female; Heart Failure; Humans; Inflammation; I | 2010 |
Low triiodothyronine and exercise capacity in heart failure.
Topics: Aged; Biomarkers; Cardiac Output; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Failure | 2012 |
Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.
Topics: Aged; Biomarkers; Cardiomyopathy, Dilated; Chi-Square Distribution; Chronic Disease; Down-Regulation | 2010 |
Myxoedematous pre-coma and heart failure.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Heart Failure; Humans; Hypo | 2011 |
Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage.
Topics: Aged; Biomarkers; Cardiomyopathy, Dilated; Echocardiography; Electric Impedance; Exercise Test; Fema | 2011 |
Effect of cardiac resynchronization therapy on thyroid function.
Topics: Adult; Aged; Biomarkers; Cardiac Resynchronization Therapy; Female; Heart Failure; Humans; Male; Mid | 2011 |
Thyroid hormone promotes remodeling of coronary resistance vessels.
Topics: Angiopoietins; Animals; Cell Proliferation; Coronary Vessels; Disease Models, Animal; Echocardiograp | 2011 |
Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
Topics: Age Factors; Aged; Blood Pressure; Diabetes Mellitus; Diastole; Echocardiography; Female; Heart Fail | 2012 |
Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway.
Topics: Aged; Coronary Disease; Female; Heart Failure; Hospitalization; Humans; Hypothyroidism; Male; Middle | 2012 |
The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Chronic Disease; Female; Heart Failure; Humans; | 2012 |
[Changes and clinical significance of serum thyroxine level in patients with congestive heart failure].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Heart Failure; Humans; Male; Middle Aged; Thyrox | 1999 |
[Troiiodothyronine in treatment of hypometabolic states].
Topics: Child; Heart Failure; Humans; Hypothyroidism; Infant; Triiodothyronine | 1958 |
Water retention in obesity.
Topics: Heart Failure; Kidney Function Tests; Obesity; Triiodothyronine; Water-Electrolyte Balance | 1959 |
THE DIALYSIS OF I-131 TRIIODOTHYRONINE FROM PLASMA: AN IN VITRO TEST OF THYROID FUNCTION.
Topics: Atrial Fibrillation; Dialysis; Erythrocytes; Heart Failure; Hyperthyroidism; Hypothyroidism; In Vitr | 1965 |
Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart.
Topics: Animals; Calcium-Transporting ATPases; Cells, Cultured; Disease Models, Animal; Disease Progression; | 2003 |
[Changes of thyroid hormone levels in the progression of coronary arteriosclerosis].
Topics: Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Heart Fail | 2004 |
[Study on relationship among thyroid hormone relativity and Syndrome Differentiation-types of TCM in patients with congestive heart failure].
Topics: Adult; Aged; Atrial Natriuretic Factor; Diagnosis, Differential; Female; Heart Failure; Humans; Male | 2004 |
Triiodothyronine levels for risk stratification of patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Ag | 2005 |
[Prolactin (PRL), thyrotropin (TSH), free thyroid hormones (fT4), (fT3) and testosterone (TTE) level in men with chronic heart failure].
Topics: Adult; Aged; Biomarkers; Fluorescent Antibody Technique; Heart Failure; Humans; Male; Middle Aged; P | 2005 |
[Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hypothyroidism; Inci | 2005 |
Low triiodothyronine (T3) or reverse triiodothyronine (rT3) syndrome modifies gene expression in rats with congestive heart failure.
Topics: Animals; Euthyroid Sick Syndromes; Gene Expression Regulation; Heart Failure; Heart Ventricles; Male | 2005 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Relationship between low T3 syndrome and NT-proBNP levels in non-cardiac patients.
Topics: Aged; Disease Progression; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Peptide | 2007 |
Thyroid hormone treatment to mend a broken heart.
Topics: Heart Failure; Humans; Triiodothyronine | 2008 |
Inappropriate antidiuretic hormone secretion and myxedema: hazards in management.
Topics: Aged; Heart Failure; Humans; Hyponatremia; Hypopituitarism; Male; Myxedema; Propylthiouracil; Triiod | 1967 |
[Relation between thyroid hormone concentration of the blood and the blood collection site and circulatory status].
Topics: Adult; Aorta; Coronary Vessels; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Pulmonary | 1983 |
[Evaluation of thyroid activity in chronic circulatory insufficiency using the T3 and resin uptake tests].
Topics: Aged; Chronic Disease; Female; Heart Failure; Humans; Iodine Radioisotopes; Ion Exchange Resins; Mal | 1980 |
Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Echocardiography; Female; Heart Failure; Hu | 1995 |
A common factor for cardiac or respiratory failure in SIDS.
Topics: Heart Failure; Humans; Infant; Linoleic Acid; Linoleic Acids; Prone Position; Respiratory Insufficie | 1995 |
Thyroid function in dogs with spontaneous and induced congestive heart failure.
Topics: Animals; Dog Diseases; Dogs; Female; Heart Failure; Male; Thyroid Gland; Thyrotropin; Thyroxine; Tri | 1994 |
[Serum thyroid hormone levels correlate with cardiac function and ventricular tachyarrhythmia in patients with chronic heart failure].
Topics: Echocardiography; Female; Heart; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Tachycardia, | 1993 |
Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure.
Topics: Basal Metabolism; Heart Failure; Hemodynamics; Humans; Triiodothyronine | 1993 |
Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure.
Topics: Animals; Captopril; Cardiac Output; Cattle; Diiodothyronines; Heart Failure; Hemodynamics; Humans; P | 1993 |
Participation of the pituitary-thyroid axis in the cardiovascular system in elderly patients with congestive heart failure.
Topics: Aged; Atrial Natriuretic Factor; Cardiovascular System; Euthyroid Sick Syndromes; Female; Heart Fail | 1997 |
Thyroid hormone treatment of congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Triiodothyronine | 1998 |
When the thyroid speaks, the heart listens.
Topics: Animals; Calcium-Transporting ATPases; Disease Models, Animal; Gene Expression Profiling; Gene Expre | 2001 |
[Effect of ginseng injection in treating congestive heart failure and its influence on thyroid hormones].
Topics: Adult; Aged; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Mid | 1999 |
Managing patients with acute thyrotoxicosis.
Topics: Acute Disease; Administration, Oral; Adult; Antithyroid Agents; Female; Heart Failure; Humans; Potas | 2002 |
Heart failure accompanied by sick euthyroid syndrome and exercise training.
Topics: Aged; Atrial Function, Left; Euthyroid Sick Syndromes; Exercise Test; Exercise Therapy; Female; Hear | 2002 |
Diagnosis of hyperthyroidism when serum-thyroxine alone is raised.
Topics: Adult; Aged; Delirium; False Negative Reactions; Female; Follow-Up Studies; Gastroenteritis; Graves | 1977 |
Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Carbimazole; Female; Heart Failure; Humans; Hyperthyroidi | 1979 |
[Minimal cardiac transit time in thyroid disorders and in the effort syndrome].
Topics: Adult; Blood Flow Velocity; Cardiomyopathies; Diagnosis, Differential; Female; Heart; Heart Failure; | 1975 |
Plasma free fatty acids, inhibitor of extrathyroidal conversion of T4 to T3 and thyroid hormone binding inhibitor in patients with various nonthyroidal illnesses.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Binding, Competitive; Carrier Proteins; Diabetes Mell | 1992 |
Altered thyroid hormone metabolism in advanced heart failure.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middl | 1990 |
Diagnosis and management of hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Female; Heart Failure; Humans; Hyperthyroidism; Inf | 1986 |
Primary hypothyroidism in severe chronic heart failure.
Topics: Adult; Aged; Cardiomegaly; Euthyroid Sick Syndromes; Female; Heart Failure; Heart Function Tests; Hu | 1988 |
Effect of oral frusemide on diagnostic indices of thyroid function.
Topics: Administration, Oral; Furosemide; Heart Failure; Humans; Thyroid Function Tests; Thyroid Gland; Thyr | 1987 |
[The determination of the "free thyroxine" index in internal diseases].
Topics: Diagnosis, Differential; Erythrocytes; Heart Diseases; Heart Failure; Humans; Hyperthyroidism; Hypot | 1967 |
Letter: Serum digoxin and thyroid hormones.
Topics: Digoxin; Heart Failure; Humans; Iodine Radioisotopes; Male; Radioimmunoassay; Thyroxine; Triiodothyr | 1974 |